Article Text

Download PDFPDF
CASE REPORT
Waldenstrom's macroglobulinaemia: to treat or not to treat?
  1. Deepak Sundriyal1,
  2. Naveen Kumar2,
  3. Sumedha Kotwal1,
  4. Nikhil Shirsi1
  1. 1Department of Medical Oncology, Dharamshila Hospital and Research Centre, New Delhi, India
  2. 2Department of Internal Medicine, PGIMER & Dr Ram Manohar Lohia Hospital, New Delhi, India
  1. Correspondence to Dr Naveen Kumar, docnaveen2605{at}yahoo.co.in

Summary

Waldenstrom's macroglobulinaemia (WM) is a rare lymphoproliferative disorder. It is mostly seen in the elderly population with a median age of 65 years at the time of diagnosis. The clinical presentation is variable and the patient may be entirely asymptomatic. The slow progressive nature of the disease allows many patients to survive for more than 5 years. At times it may be difficult for a clinician to determine the timing of therapy. We present an interesting case of WM that highlights the typical course of the disease and timing of its management.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.